Group 2G: Triple Negative Breast Cancer; Predictive Biomarkers; Antibody-drug Conjugates

Name: Group 2G: Triple Negative Breast Cancer; Predictive Biomarkers; Antibody-drug Conjugates
Start: 2023-12-14
End: 2023-12-14

Poster #PO5-06-13: Impact of therapy on sites of metastases in triple negative breast cancer.

Poster #PO4-14-10: Circulating tumor DNA as a biomarker for ADCs in metastatic breast cancer.